Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
Oncogene|April 12, 2002
AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimersKazumi Suzukawa, Nancy H ColburnMolecular Cancer Research : MCR|March 10, 2005
Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA bindingJing Hu, Nancy H ColburnCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2002
Molecular targets for cancer prevention: a meeting review of the third American Cancer Society-Schilling Research ConferenceDawn B Willis, Nancy H ColburnGene|June 21, 2006
Fra-1 a target for cancer prevention or interventionMatthew R Young, Nancy H ColburnMolecular and Cellular Biochemistry|August 7, 2002
The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictiveArindam Dhar, Mathew R Young, Nancy H ColburnEnvironmental Health Perspectives|September 3, 2002
AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 modelKazumi Suzukawa, Thomas J Weber, Nancy H ColburnCurrent Cancer Drug Targets|November 6, 2007
AP-1 a target for cancer preventionConnie P Matthews, Nancy H Colburn, Matthew R YoungCarcinogenesis|June 12, 2004
Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cellsJing Hu, Hiroyasu Nakano, Hiroaki Sakurai, et al.Cancer Research|July 19, 2005
Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesisAaron P Jansen, Corinne E Camalier, Nancy H ColburnTrends in Molecular Medicine|January 14, 2003
Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4Matthew R Young, Hsin-Sheng Yang, Nancy H ColburnPageof 10